119th Congress · House

HR. 1843

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

committee
Introduced 2025-03-05•Latest 2025-03-05
Origin chamber
House
Cosponsors
1
Latest action
Referred to the House Committee on Energy and Commerce.
Subjects
Health

Key actions

  1. 2025-03-05IntroReferral
    Introduced in House
  2. 2025-03-05IntroReferral
    Introduced in House
  3. 2025-03-05IntroReferral
    Referred to the House Committee on Energy and Commerce.

Bill text versions

Related bills

  • S. 1302 (119) · Related bill
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • S. 891 (119) · Related bill
    Read twice and referred to the Committee on Finance.
  • HR. 1768 (119) · Related bill
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
← Back to Bills